Root Financial Partners’s Abeona Therapeutics ABEO Stock Holding History

Root Financial Partners’s Portfolio ABEO Stock Details ABEO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$95	Buy	+18	New	+$112	﹤0.01%	3654

Other funds holding ABEO

Y-Intercept (HK) Hong Kong $4.52B AUM 6.6% 1-Year Est. Return

Harbor Capital Advisors Chicago, Illinois $1.48B AUM 30.88% 1-Year Est. Return

Nisa Investment Advisors St. Louis, Missouri $34.7B AUM 25.93% 1-Year Est. Return

GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return

Sterling Capital Management Charlotte, North Carolina $4.92B AUM 24.73% 1-Year Est. Return

SBI Securities Tokyo, Japan $4.38B AUM 56.37% 1-Year Est. Return

Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return

Beacon Investment Advisory Services Morristown, New Jersey $2.66B AUM 29.77% 1-Year Est. Return

Fortitude Family Office Scottsdale, Arizona $586M AUM 20.58% 1-Year Est. Return

Root Financial Partners's ABEO Position: Q3 2026 in Review

Root Financial Partners opened a new position in Abeona Therapeutics (ABEO) in Q3 2026: 18 shares worth $95. The stake represents ﹤0.01% of the portfolio and ranks #3654 among its holdings.

10 funds tracked by Wall St. Rank hold ABEO as of Q3 2026.

Root Financial Partners held 18 shares of Abeona Therapeutics worth $95 as of Q3 2026.
Abeona Therapeutics was a new Root Financial Partners position in Q3 2026.
Abeona Therapeutics made up ﹤0.01% of Root Financial Partners's portfolio in Q3 2026, its #3654 holding.
10 funds tracked by Wall St. Rank held Abeona Therapeutics as of Q3 2026.

Based on Root Financial Partners's 13F filing for Q3 2026, filed 21 Oct 2026.